Open Access

New dimensions in the management of cardiovascular disease in type 2 diabetes

Event: ESC Congress 2018
Topic: Cardiovascular Disease in Special Populations
Session type: Satellite Symposium - Experts on the Spot
Sponsored by Novo Nordisk A/S
Date: 28 August 2018
Time: 16:00 - 16:30

Session

3 presentations in this session

New dimensions in the management of cardiovascular disease in type 2 diabetes.

Speaker: Professor J. Deanfield (London, GB)
Thumbnail

Debated aspects: glucagon-like peptide-1 receptor agonists for high vs low cardiovascular risk.

Speaker: Professor J. Deanfield (London, GB)
Speaker: Doctor F. Persson (Herlev, DK)
Thumbnail

Discussion: connecting cardiovascular outcome trial results to clinical decision-making.

Speaker: Professor J. Deanfield (London, GB)
Speaker: Doctor F. Persson (Herlev, DK)
Thumbnail

5 speakers from this session

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
36 presentations
1 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
36 presentations
1 follower

Doctor Frederik Persson

Steno Diabetes Center, Copenhagen, Herlev (Denmark)
2 presentations
0 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
36 presentations
1 follower

Doctor Frederik Persson

Steno Diabetes Center, Copenhagen, Herlev (Denmark)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk